References
- Sugaya N, Kaiya H, Kumano H, Nomura S. Relationship between subtypes of irritable bowel syndrome and severity of symptoms associated with panic disorder. Scand J Gastroenterol 2008; 43: 675–81
- Park JH. Prevalence and risk factors of irritable bowel syndrome in Korean adolescent girls: a school-based study. 1 9th Int Nursing Research Congress Focusing on Evidence-Based Practice 2008.
- Riedl A, Schmidtmann M, Stengel A, Goebel M, Wissen AS, Klapp BV, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008; 64: 573–82
- Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 2008; 57: 468–73
- Farnam A, Somi MH, Sarami F, Farhang S, Yasrebinia S. Personality factors and profiles in variants of irritable bowel syndrome. World J Gastroenterol 2007; 13: 6414–8
- Shufflebotham J, Wetherell MA, Hince D, Hood S, Lightman S, Nutt D, et al. Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge. Stress 2008; 1: 000–00
- McCrone P, Knapp M, Kennedy T, Seed P, Jones R, Darnley S, et al. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. Eur J Gastroenterol Hepatol 2008; 20: 255–63
- Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, et al. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2008; 27: 678–84
- Rahimi R, Nikfar S, Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: a meta-analysis of randomized controlled trials. Arch Med Sci 2008; 4: 71–6